(Q42446554)

31 October 2017

Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era. (English)

1 reference

31 October 2017

1 reference

Aspergillus

1 reference

5

1 reference

31 October 2017

Jesús Guinea

1

1 reference

31 October 2017

Sandra Recio

series ordinal

2

1 reference

31 October 2017

Teresa Peláez

series ordinal

3

1 reference

31 October 2017

Marta Torres-Narbona

series ordinal

4

1 reference

31 October 2017

language of work or name

English

0 references

publication date

7 July 2008

1 reference

Antimicrobial Agents and Chemotherapy

31 October 2017

1 reference

31 October 2017

52

1 reference

31 October 2017

9

1 reference

31 October 2017

3444-3446

1 reference

In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species

31 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

Acquired itraconazole resistance in Aspergillus fumigatus

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

Multi-azole resistance in Aspergillus fumigatus

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2533497

Multiple-Triazole–Resistant Aspergillosis

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18606840

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. acquired resistance to itraconazole

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18606840

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00629-08

1 reference

31 October 2017

1 reference

31 October 2017

1 reference